UK Information

UK Sativex Website

Sativex® is approved in the UK as a prescription medicine for the treatment of spasticity due to multiple sclerosis

Information on Sativex including information on how
to access Sativex on the NHS is provided by:

MS Society Factsheet

MS Society NHA Access Document

MS Trust Factsheet

Please note: GW is not responsible for the information
on external links

On Monday the 21st of June, Dr Geoffrey Guy, chairman of GW Pharmaceuticals, gave an interview to CNBC about Sativex. If you would view this interview online please click on the link below:

interview